Mr. Prasanth Manghat is the deal maker of the yearNovember 14, 2016 Healthcare News
Sophie Le Ray, CEO, Naseba awards Prasanth Manghat, Deputy CEO, NMC Healthcare with ‘Deal Maker of the Year’ Award
The 10th CFO Strategies Forum MENA conferred Prasanth Manghat, Deputy CEO of NMC Healthcare with the ‘Deal Maker of the Year’ Award. At the event held in Dubai on 07th November, Prasanth was recognized for spearheading the acquisition of Fakih IVF Group into NMC’s extensive gamut of healthcare businesses. NMC now holds 51% share of the Middle-East’s leading player in in-vitro fertilization services.
The deal was valued at 696 million dirhams and comprises of Fakih IVF LLC and Fakih Fertility Centre LLC, which perform over 4,000 cycles per annum and offer the only full service genetics laboratory in the region. Fakih IVF currently operates centers in both Abu Dhabi & Dubai and is looking to expand its footprint in the GCC region.
Prasanth Manghat strategized the deal to align with NMC’s Group strategy of establishing the company as a top integrated provider of specialist care and his vision to invigorate NMC as the global leader in maternity and fertility vertical.
Prasanth Manghat is also attributed to the group’s listing at the London Stock Exchange and the phenomenal journey of the stock since then.
French company Naseba, is a business-to-business events organiser focusing on emerging markets. The French company launched in Monaco in 2002, opened its Dubai office two years later and is today a much reputed knowledge management and capability development organization.
About NMC Health
NMC Health plc is the leading private sector healthcare operator based out of the United Arab Emirates. The group, having started its operations in the country in 1975, has an international network of hospitals in the UAE, Europe and South America consisting of over forty healthcare facilities across 8 countries, catering to over twelve thousand patients per day, and employing over 1200 doctors looking after 1000 beds.
The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. NMC Trading, a subsidiary of NMC Health plc, is one of the largest distributors in the UAE with distribution rights for some of the most iconic brands from around the world, including 3M, Medtronic, Welch Allyn, Meyra, Sorg, Patron, Abbott Diabetes Care, Nestle, Unilever, Nivea, Pfizer, Siemens, Samsung, Sanofi, Kiwi, Brylcreem, and Henkel, among others. NMC Trading sells products and services to over 10,000 businesses across the UAE.
NMC Health plc reported revenues of US$880.9m in 2015. In April 2012 NMC Health plc became the first healthcare company from the GCC to list on the London Stock Exchange. NMC Health plc is a constituent of the coveted FTSE 250 Index.